Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael A. Lanphere currently holds 50,144,878 shares of TransBiotec, Inc. (IMLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael A. Lanphere has been a net buyer of IMLE stock. They have purchased $520.6K and sold $0 worth of shares.
Michael A. Lanphere's most recent insider trade was on Aug 28, 2019, when they purchased 5,206,430 shares at $0.10 per share.
Michael A. Lanphere serves as Executive at TransBiotec, Inc. (IMLE). They have executed 2 insider transactions totaling $520.6K over their tenure at the company.
Michael A. Lanphere holds the position of Executive at TransBiotec, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michael A. Lanphere has shown a buying trading pattern, with $520.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael A. Lanphere was on Aug 28, 2019, when they purchased $520.6K worth of IMLE shares. This transaction involved 5,206,430 shares at $0.10 per share.
Michael A. Lanphere currently owns 50,144,878 shares of TransBiotec, Inc. (IMLE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael A. Lanphere's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael A. Lanphere has 2 Form 4 filings on record as an insider at TransBiotec, Inc..
Set alerts for Michael A. Lanphere and 40,000+ other insiders.